Caspase 1

Caspase 1, also known as interleukin-1β converting enzyme (ICE), is a protease enzyme that plays a critical role in the regulation of inflammation and apoptosis. It is part of the caspase family, a group of enzymes that are key mediators of programmed cell death and inflammation.
Caspase 1 is synthesized as an inactive zymogen that requires processing for activation. This processing can occur through several pathways, but it is most commonly activated within a multiprotein complex known as the inflammasome. The inflammasome facilitates the cleavage of pro-caspase 1 into its active form, which then goes on to process pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18) into their active forms. These cytokines are crucial for the immune response, mediating fever, inflammation, and sepsis.
The regulation of caspase 1 and its activation within the inflammasome is a subject of intense research, as dysregulation of these processes is associated with a variety of diseases, including autoimmune diseases, inflammatory diseases, and cancer. Understanding the mechanisms controlling caspase 1 activation and function is critical for the development of therapeutic strategies targeting these conditions.
Caspase 1 also plays a role in pyroptosis, a form of programmed cell death that is distinct from apoptosis and is characterized by cell swelling, membrane rupture, and the release of pro-inflammatory cellular contents. Pyroptosis is considered a form of innate immune defense against microbial infections, but excessive or inappropriate activation can contribute to tissue damage and disease.
Caspase_1[edit]
-
Caspase-1 Zymogen
-
Subunits of inhibited Caspase 1
-
Inflammasome vector
-
CARD-CARD ring
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian